NCT03078361 is a NA clinical trial of Immunochemical Fecal Occult Blood Test (I-FOBT) Kit in Colorectal Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Who is sponsoring NCT03078361?

NCT03078361 is sponsored by H. Lee Moffitt Cancer Center and Research Institute.

What drugs are being tested in NCT03078361?

Interventions in NCT03078361: Immunochemical Fecal Occult Blood Test (I-FOBT) Kit, LATINOS CARES Toolkit, Standard Intervention.

What condition does NCT03078361 study?

NCT03078361 studies Colorectal Cancer, Colorectal Carcinoma.

Is NCT03078361 still recruiting?

NCT03078361 is currently completed. Last updated 11 January 2023.

Last reviewed 2023-01-11 · How we verify

NCT03078361

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening)

Completed NA Last updated 11 January 2023

What this trial tests

NA trial testing Immunochemical Fecal Occult Blood Test (I-FOBT) Kit in Colorectal Cancer in 159 participants. Completed in 26 October 2022.

Timeline

28 April 2014

Primary endpoint
14 July 2016

26 October 2022

Quick facts

Lead sponsor	H. Lee Moffitt Cancer Center and Research Institute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	159
Start date	28 April 2014
Primary completion	14 July 2016
Estimated completion	26 October 2022
Sites	1 location across United States

Drugs / interventions tested

Immunochemical Fecal Occult Blood Test (I-FOBT) Kit
LATINOS CARES Toolkit
Standard Intervention

Conditions studied

Colorectal Cancer — all drugs for Colorectal Cancer →
Colorectal Carcinoma — all drugs for Colorectal Carcinoma →

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Who can join

Adults 50 to 70, any sex, with Colorectal Cancer or Colorectal Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to conduct 4 focus groups and recruit for 12 participants per focus group to explore community members' views about colorectal cancer screening (CRCS) processes and perceived benefits and impediments, what information they believe should be communicated, communication preferences (style, tone) and perceptions of screenings.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Characterizing Health Literacy Among Spanish Language-Preferring Latinos Ages 50-75.
Christy SM, Cousin LA, Sutton SK, Chavarria EA, et al · · 2021 · cited 20× · PMID 33990120 · DOI 10.1097/nnr.0000000000000519
Online Health Information Seeking and eHealth Literacy Among Spanish Language-Dominant Latino Adults Receiving Care in a Community Clinic: Secondary Analysis of Pilot Randomized Controlled Trial Data.
Chavarria EA, Christy SM, Feng H, Miao H, et al · · 2022 · cited 8× · PMID 35238785 · DOI 10.2196/37687

Verify or expand the search:

Other trials of Immunochemical Fecal Occult Blood Test (I-FOBT) Kit

Trials testing the same drug.

NCT01804179 — Colorectal Cancer Awareness, Research, Education and Screening (CARES) · NA · completed

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting

Other H. Lee Moffitt Cancer Center and Research Institute trials

Trials by the same sponsor.

NCT05041335 — Wet Heparinized Suction for Abdominal Cancer · NA · not yet recruiting
NCT07222995 — Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs · NA · recruiting
NCT06047977 — Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors · Phase 1 · recruiting
NCT06121180 — Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma · Phase 2 · recruiting
NCT06193486 — Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03078361 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by H. Lee Moffitt Cancer Center and Research Institute
Last refreshed: 11 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03078361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing